This resource includes hand-crafted patent highlights featuring synthetically lethal Pol inhibitors from linkedin_mention(urn:li:organization:1603|AstraZeneca) and linkedin_mention(urn:li:organization:1399|GSK) , SARM1 Inhibitors for neurodegenerative indications and our best guess at the identity of linkedin_mention(urn:li:organization:163993|Gilead Sciences) ' small molecule GLP-1R agonist GS-4571 Full article | Drug Hunters Post June 2024 Patent Highlights: GLP-1R Agonists, Pol Inhibitors, Non-Ab PD-L1 Inhibitors and More
When your overall health is being managed well, peptide therapy amplifies the results
While their mechanisms of action are similar, topical acetyl hexapeptide-8 does demonstrate a lower efficacy than injected Botox, but as researchers note this is to be expected.22 Similar results were found in a small 2013 study, with the total anti-wrinkle efficacy of the Argireline treatment group being 48.9% compared to 0% in the placebo group.23 However, a more recent 2023 study investigating the effects of serum containing Argireline and hyaluronic acid found the results to be not statistically significant.24 This means that more research is needed before claims that Argireline is a true alternative to Botox can be confirmed or denied
MACE, Major adverse cardiovascular events
Hadi, A., Pourmasoumi, M., Najafgholizadeh, A., T
Marys Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea 3 Division of Endocrinology and Metabolism, Department of Internal Medicine, Eunpyeong St
